Public case informationLast updated

Grail Investor Securities Class Action

Grail · Grail common stock and NHS-Galleri cancer screening product · Ongoing Litigation

About this case

A securities class action was filed on behalf of investors who purchased or otherwise acquired Grail securities, alleging investor losses related to the company’s conduct. The matter was filed, and a deadline to seek appointment as lead plaintiff was set for August 4, 2026; its later procedural stage is not specified.

Case overview

Defendant company
Grail
Product or service
Grail common stock and NHS-Galleri cancer screening product
Case name
Grail Securities Class Action
Court case number
4:2026cv05428
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Lead Plaintiff Motion

Participation information

Lead Plaintiff Motion

Investors who purchased or otherwise acquired Grail securities may have been able to seek appointment as lead plaintiff, subject to the court’s requirements.

A lead plaintiff motion was required to be filed by August 4, 2026.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear

Faruqi & Faruqi investor inquiry

Investors who suffered losses in Grail, as well as people with information about Grail’s conduct, are encouraged to contact Faruqi & Faruqi.

Contact Faruqi & Faruqi, LLP directly to discuss available options.

Type
Law Firm Signup

Bronstein, Gewirtz & Grossman investor inquiry

The article invites GRAIL investors to contact the law firm regarding the securities class action, but does not specify eligibility requirements.

Contact Bronstein, Gewirtz & Grossman using the contact information provided in the article.

Type
Law Firm Signup
Reported proof requirement
Unclear

Lead Plaintiff Inquiry

Investors who suffered substantial losses may provide their information to inquire about serving as lead plaintiff.

Provide your information through the law firm's case page.

Type
Law Firm Signup

Sources